Donor safety of remnant liver volumes of less than 30% in living donor liver transplantation: A systematic review and meta-analysis [0.03%]
供肝剩余量低于30%的活体肝脏捐献者安全性：系统评价和Meta分析
Sang-Hoon Kim,Ki-Hun Kim,Hwui-Dong Cho
Sang-Hoon Kim
Purpose: This meta-analysis aimed to investigate the acceptability of donor remnant liver volume (RLV) to total liver volume (TLV) ratio (RLV/TLV) being
Mycophenolic acid therapeutic drug monitoring using area under the curve in pediatric heart transplant recipients [0.03%]
儿科心脏移植受者中使用曲线下面积对霉酚酸进行药物浓度监测
David M Newland,Jennifer L Pak,Reda Ali et al.
David M Newland et al.
Introduction: Pharmacokinetics of mycophenolic acid (MPA) display substantial interpatient variability, with up to 10-fold difference of exposure in individual patients under a fixed-dose regimen. MPA trough level (C0) mo...
The stability of the gut, oral, and circulating microbiomes in living kidney donors: A 2 years prospective study [0.03%]
活体肾脏捐献者肠道、口腔和循环微生物组的稳定性：一项为期两年的研究
Ricardo Araujo,Ana Merino Ribas,Susana Sampaio et al.
Ricardo Araujo et al.
Retrospective evaluation of LCP-tacrolimus (Envarsus XR) dosing in de novo kidney transplant [0.03%]
德诺肾脏移植受者中LCP-他克莫司(Envarsus XR)剂量回顾性评估
Mohammed Alzahrani,Rachel M Belcher,Jamie Benken et al.
Mohammed Alzahrani et al.
Introduction: Tacrolimus is known to exhibit significant inter- and intra-patient pharmacokinetic (PK) and pharmacodynamic (PD) variability regarding therapeutic response. LCP-tacrolimus (LCPT-Envarsus XR) was approved in...
Successful liver transplantation from deceased donors with active COVID-19 infections with undetectable SARS-CoV-2 in donor liver and aorta [0.03%]
成功为COVID-19阳性供体器官受体进行肝移植手术
Sharon R Weeks,Ekateria Federova,Kyungho Lee et al.
Sharon R Weeks et al.
Background: The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has had unprecedented effects on society and modern healthcare. In liver transplantation, uncertainty regarding the safety of performing transplants durin...
Local laboratory-run donor-derived cell-free DNA assay for rejection surveillance in heart transplantation-first six months of clinical experience [0.03%]
心脏移植术后前六个月使用局部实验室运行的供体来源的无细胞DNA检测进行排斥监测的临床经验
Timea Teszak,Csaba Bödör,Lajos Hegyi et al.
Timea Teszak et al.
Introduction: Donor-derived cell-free DNA (dd-cfDNA) is a blood biomarker detecting graft injury with high negative predictive value. While non-invasive strategies for heart transplant (HTx) rejection surveillance are wid...
Implementation of routine Clostridioides difficile infection (CDI) primary prophylaxis in lung transplant recipients [0.03%]
肺移植受者中艰难梭菌感染(CDI)初级预防措施的实施
Mary Grace Fitzmaurice,Benjamin Hohlfelder,Pavithra Srinivas et al.
Mary Grace Fitzmaurice et al.
Lung transplant recipients are at an increased risk for Clostridioides difficile infection (CDI), and those who develop CDI post-transplant can have worsened outcomes including graft failure and death. We sought to describe the efficacy and...
Percentage of low attenuation area on computed tomography detects chronic lung allograft dysfunction, especially bronchiolitis obliterans syndrome, after bilateral lung transplantation [0.03%]
胸部CT低衰减区占比可检测双肺移植术后的慢性移植物肺病，尤其是闭塞性细支气管炎
Yujiro Kubo,Seiichiro Sugimoto,Toshio Shiotani et al.
Yujiro Kubo et al.
Introduction: The percentage of low attenuation area (%LAA) on computed tomography (CT) is useful for evaluating lung emphysema, and higher %LAA was observed in patients with chronic lung allograft dysfunction (CLAD). Thi...
Pei Jun Zhao,David Drullinsky,Dave Nagpal et al.
Pei Jun Zhao et al.
COVID-19 Vaccine Seroresponse Based on The Timing of The Primary Series; Pre- versus Post-Renal Transplantation [0.03%]
基于接种时机的新冠疫苗血清学反应：移植前与移植后
Amy R Weinberg,Calvin O Caeg,Robyn DePalma et al.
Amy R Weinberg et al.
Background: Coronavirus disease 2019 (COVID-19) poses a serious risk to patients with chronic kidney disease (CKD) and renal transplant. While COVID-19 vaccination is recommended before transplant, there are limited data ...